Internet Archive Scholar

Less drug regimens and PI/r-based strategies in HIV infection: focus on best practices using the HIV patient's journey methodology

Simone Marcotullio, Adriana Ammassari, Massimo Andreoni, Andrea Antinori, Stefano Bonora, Antonella d'Arminio Monforte, Giovanni Di Perri, Massimo Galli, Cristina Gervasoni, Rosaria Iardino, Giuseppe Ippolito, Sergio Lo Caputo (+4 others)
2014 The New Microbiologica  

Preserved Fulltext

fulltext thumbnail
Web Archive Capture PDF (739.6 kB)
https://web.archive.org/web/20170808083757/http://www.newmicrobiologica.org/PUB/allegati_pdf/2014/2/163.pdf

A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2017; you can also visit the original URL. The file type is application/pdf.

During these last two years less drug regimens (LDRs) in HIV, and in particular protease inhibitor (PI)/r-based strategies, have been explored both in clinical trials and in clinical practice. Many results are now available and more is known about how to use them safely and effectively. Understanding that an LDR strategy represents a real tailored therapeutic approach for the patient is crucial for the long-term success and positive management of HIV infection. Trust between patients and HIV
more » ... cialists and a real focus on the patient's life are key factors for long life treatment success, in particular when using a LDR strategy. This is clearly shown by the HIV patient's journey (HPJ) methodology, used in an Italian national workshop to better define the criteria and challenges of LDR strategies. This paper shows the results of this complex process.
pmid:24858643 fatcat:v4s722mevncjpcgjb365ryk6ye
Citation

Simone Marcotullio, Adriana Ammassari, Massimo Andreoni, Andrea Antinori, Stefano Bonora, Antonella d'Arminio Monforte, Giovanni Di Perri, Massimo Galli, Cristina Gervasoni, Rosaria Iardino, Giuseppe Ippolito, Sergio Lo Caputo, Silvia Nozza, Carlo Federico Perno, Giuliano Rizzardini, Adriano Lazzarin. "Less drug regimens and PI/r-based strategies in HIV infection: focus on best practices using the HIV patient's journey methodology." The New Microbiologica 37.2 (2014) 163-75